Sientra, Inc. Launches Industry First-Ever Patient-Centric Capsular Contracture Care Program

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Sientra, a privately-held medical device company focused on plastic surgery and aesthetic medicine, announced the launch of its Capsular Contracture Care program, or C3, a first-of-its-kind protection program for women seeking primary breast augmentation. With this program, women will finally have the comfort of knowing there is assistance in the event they experience capsular contracture, a tightening of the scar tissue around the breast implant that can occasionally cause the breast to feel too firm. Women who receive any shape, size or style of Sientra’s textured breast implants featuring TRUE Texture™ will be eligible for a free-of-charge product replacement if they develop capsular contracture of the breast requiring revision surgery within two years of implantation.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC